1. Long-term Care After Percutaneous Coronary Intervention: Focus on the Role of Antiplatelet Therapy 
Gregg W. Stone, MD, Herbert D. Aronow, MD, MPH 
Mayo Clinic Proceedings 
Volume 81, Issue 5, Pages (May 2006)
DOI: /
Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions

2. FIGURE 1
Factors involved in platelet aggregation and the points of action (parallel lines) of various antithrombotic and anticoagulant drugs. ADP = adenosine diphosphate; LMWHs = low-molecular-weight heparins; UFH = unfractionated heparin. From Am J Cardiovasc Drugs,10 with permission from Wolters Kluwer Health.
Mayo Clinic Proceedings  , DOI: ( / )
Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions

3. FIGURE 2
Mechanisms of action of antiplatelet drugs and the routes to inhibiting platelet function. ADP = adenosine diphosphate; GP = glycoprotein. From BMJ,53 with permission from BMJ Publishing Group Ltd.
Mayo Clinic Proceedings  , DOI: ( / )
Copyright © 2006 Mayo Foundation for Medical Education and Research Terms and Conditions